Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Zepbound (tirzepatide) is a prescription drug used to help with weight loss and sleep apnea in certain ... for OSA is the same as shown in this chart, except that the typical maintenance dosage ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.

Zepbound is a brand-name drug prescribed for weight loss and long-term weight maintenance in certain adults with obesity or overweight. Zepbound is also approved to treat severe obstructive sleep ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for ... there’s no longer a shortage of weight-loss drugs that had allowed for alternatives ...

Investing.com - Eli Lilly (NYSE:LLY) announced on Tuesday that it would begin selling 7.5 milligram and 10 milligram single-dose vials of its Zepbound weight-loss drug at a roughly $150 discount ...